• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.

     

    Find out more about it and REGISTER today!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • ConventionCALL FOR: Podium and Poster Abstracts

    For the 38th GAPNA Annual Conference
    at the Hyatt Regency
    New Orleans, LA, September 24-26, 2020

    GAPNA members are invited to submit an abstract about their innovative work, that should enrich the APRN's knowledge and/or enhance the care of an older adult.

    Find out more info and deadline dates

  • FREE continuing education credit is available for the following session:

    "Meaningful Conversations throughout the Course of Illness"

    (session captured at the GAPNA 2018 Annual Conference)


    For November/December 2019 - Get Your Free CNE Now!

Most Nursing Home Residents with Advanced Dementia Get Medications With Questionable Benefits and Substantial Costs

More than half of nursing home residents with advanced dementia continue to receive medications that may not help them, but incur substantial financial cost.

An analysis of more than 5,400 residents at 460 facilities (using 2009-2010 data) found nearly 54% of residents received at least one medication of questionable benefit.

The average 90-day expenditure for medications with questionable benefits was $816.

This accounts for 35.2% of the total average 90-day medication costs for residents with advanced dementia who were prescribed common medications with questionable benefits.

To learn more, see Tjia et al. (2014). Use of medications of questionable benefit in advanced dementia. JAMA Internal Medicine, 174(11), 1763-1771.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: